EFFECTIVENESS OF NETILMICIN AND TOBRAMYCIN AGAINST PSEUDOMONAS-AERUGINOSA INVITRO AND IN AN EXPERIMENTAL TISSUE INFECTION IN MICE

被引:6
作者
MOFFIE, BG [1 ]
HOOGETERP, JJ [1 ]
LIM, T [1 ]
DOUWESIDEMA, AE [1 ]
MATTIE, H [1 ]
机构
[1] UNIV HOSP LEIDEN,DEPT INFECT DIS,POB 9600,2300 RC LEIDEN,NETHERLANDS
关键词
D O I
10.1093/jac/31.3.403
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The activity of netilmicin and tobramycin against Pseudomonas aeruginosa was assessed in vitro in the presence of constant and exponentially declining concentrations, and in mice in an experimental thigh infection. The activity in vitro at constant concentrations was expressed as the maximal killing rate (ER) during 3 h of exposure. On the basis of the quantitative relation between E(R) and the drug concentration, the numbers of cfu expected at consecutive times, at constant as well as at declining concentrations, were predicted. The relationship between observed numbers and predicted values of ERt were similar under both conditions for both drugs. On the same basis the numbers of cfu expected in the experimental thigh infection were predicted. There was indeed a significant linear relationship between observed numbers of cfu in homogenized muscle and the values predicted on the basis of the pharmacokinetics of the aminoglycosides, but the slope of this relationship was only 0·22 There was no difference in this respect between the two antibiotics. It is concluded that the efficacy of netilmicin and tobramycin against P. aeruginosa is considerably less in vivo than in vitro, but the relation is about the same for the two drugs; therefore the slightly higher activity of tobramycin in vitro is relevant in the in-vivo situation. © 1993 The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:403 / 411
页数:9
相关论文
共 8 条
[1]   ANTIBIOTIC-THERAPY OF INFECTIONS DUE TO PSEUDOMONAS-AERUGINOSA IN NORMAL AND GRANULOCYTOPENIC MICE - COMPARISON OF MURINE AND HUMAN PHARMACOKINETICS [J].
GERBER, AU ;
BRUGGER, HP ;
FELLER, C ;
STRITZKO, T ;
STALDER, B .
JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (01) :90-97
[2]   COMPARATIVE ANTIBIOTIC DOSE-EFFECT RELATIONS AT SEVERAL DOSING INTERVALS IN MURINE PNEUMONITIS AND THIGH-INFECTION MODELS [J].
LEGGETT, JE ;
FANTIN, B ;
EBERT, S ;
TOTSUKA, K ;
VOGELMAN, B ;
CALAME, W ;
MATTIE, H ;
CRAIG, WA .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (02) :281-292
[3]  
LERNER AM, 1983, LANCET, V1, P1123
[4]   ANTIBACTERIAL ACTIVITY OF 4 CEPHALOSPORINS IN AN EXPERIMENTAL-INFECTION IN RELATION TO INVITRO EFFECT AND PHARMACOKINETICS [J].
MATTIE, H ;
VANDOKKUM, AM ;
BRUSWEIJER, L ;
KRUL, AM ;
VANSTRIJEN, E .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (03) :717-722
[5]  
Mattie H, 1990, Scand J Infect Dis Suppl, V74, P133
[6]  
MATZ GJ, 1981, AMINOGLYCOSIDE OTOTO
[7]   ANTISTAPHYLOCOCCAL ACTIVITIES OF TEICOPLANIN AND VANCOMYCIN INVITRO AND IN AN EXPERIMENTAL-INFECTION [J].
PEETERMANS, WE ;
HOOGETERP, JJ ;
HAZEKAMPVANDOKKUM, AM ;
VANDENBROEK, P ;
MATTIE, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (10) :1869-1874
[8]   INVITRO STUDIES OF NETILMICIN, A NEW AMINOGLYCOSIDE ANTIBIOTIC [J].
STEWART, D ;
BODEY, GP ;
LEBLANC, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 11 (06) :1017-1020